Brawn Biotech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 479596,
    "name": "Brawn Biotech",
    "stock_name": "Brawn Biotech",
    "full_name": "Brawn Biotech Ltd",
    "name_url": "stocks-analysis/brawn-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.80",
    "chg": 1.04,
    "chgp": "4.78%",
    "dir": 1,
    "prev_price": "21.76",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530207,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE899B01015",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "05:07 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "200 ",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brawn-biotech-479596-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4151075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrawnBiotechLtd_mojoScore_4151075.png",
        "date": "2026-08-13 08:02:31",
        "description": "Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 August 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score improved to 33.0, reflecting a mildly bullish technical trend, although its financial and valuation metrics remain under pressure."
      },
      {
        "title": "Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Deterioration",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-technical-deterioration-4144632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrawnBiotechLtd_mojoScore_4144632.png",
        "date": "2026-08-10 08:02:11",
        "description": "Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 7 August 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid a challenging market environment."
      },
      {
        "title": "When is the next results date for Brawn Biotech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-brawn-biotech-ltd-4140435",
        "imagepath": "",
        "date": "2026-08-06 23:18:14",
        "description": "The next results date for Brawn Biotech Ltd is scheduled for 13 August 2026...."
      },
      {
        "title": "Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4111727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrawnBiotechLtd_mojoScore_4111727.png",
        "date": "2026-07-21 08:06:09",
        "description": "Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Jul 2026, driven primarily by a shift in technical indicators signalling a mildly bullish trend. Despite this upgrade, the company continues to face significant challenges in valuation and financial performance, reflecting a complex investment profile for market participants."
      },
      {
        "title": "Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4099956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrawnBiotechLtd_mojoScore_4099956.png",
        "date": "2026-07-14 08:03:52",
        "description": "Brawn Biotech Ltd has been downgraded from a Sell to a Strong Sell rating as of 13 Jul 2026, reflecting deteriorating technical indicators, flat financial performance, and weakening long-term fundamentals. The company’s micro-cap status, combined with negative operating metrics and bearish market signals, has prompted a reassessment of its investment appeal."
      },
      {
        "title": "Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4091384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrawnBiotechLtd_mojoScore_4091384.png",
        "date": "2026-07-07 08:04:34",
        "description": "Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 July 2026. This change is primarily driven by a shift in technical indicators, despite the company’s ongoing fundamental challenges and flat financial performance in the latest quarter."
      },
      {
        "title": "Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Financials and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-downgraded-to-strong-sell-amid-weak-financials-and-technical-setbacks-4083862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrawnBiotechLtd_mojoScore_4083862.png",
        "date": "2026-07-02 08:05:28",
        "description": "Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 1 July 2026. This decisive change reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid flat quarterly results and ongoing operating losses."
      },
      {
        "title": "Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brawn-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4068088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BrawnBiotechLtd_mojoScore_4068088.png",
        "date": "2026-06-23 08:04:46",
        "description": "Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 June 2026, driven primarily by a marked improvement in technical indicators. However, the company’s fundamental and valuation metrics remain weak, reflecting ongoing operational challenges and a precarious financial position. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change."
      }
    ],
    "total": 430,
    "sid": "479596",
    "stock_news_url": "https://www.marketsmojo.com/news/brawn-biotech-479596"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Sep-2026",
      "details": "Newspaper Publication for 41st Notice of AGM.",
      "source": "BSE"
    },
    {
      "caption": "Intimation W.R.T Letter Sent To Shareholders As Per Reg 36",
      "datetime": "02-Sep-2026",
      "details": "Letters sent to shareholders as per Reg 36",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 41St AGM To Be Held On 29.09.2026",
      "datetime": "01-Sep-2026",
      "details": "Notice of 41st AGM to be held on 29.09.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Brawn Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 18",
          "dt": "2018-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-08-13 08:02:31

Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 August 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score improved to 33.0, reflecting a mildly bullish technical trend, although its financial and valuation metrics remain under pressure.

Read full news article

Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Deterioration

2026-08-10 08:02:11

Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 7 August 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid a challenging market environment.

Read full news article

When is the next results date for Brawn Biotech Ltd?

2026-08-06 23:18:14

The next results date for Brawn Biotech Ltd is scheduled for 13 August 2026....

Read full news article

Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-07-21 08:06:09

Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Jul 2026, driven primarily by a shift in technical indicators signalling a mildly bullish trend. Despite this upgrade, the company continues to face significant challenges in valuation and financial performance, reflecting a complex investment profile for market participants.

Read full news article

Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-07-14 08:03:52

Brawn Biotech Ltd has been downgraded from a Sell to a Strong Sell rating as of 13 Jul 2026, reflecting deteriorating technical indicators, flat financial performance, and weakening long-term fundamentals. The company’s micro-cap status, combined with negative operating metrics and bearish market signals, has prompted a reassessment of its investment appeal.

Read full news article

Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-07-07 08:04:34

Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 July 2026. This change is primarily driven by a shift in technical indicators, despite the company’s ongoing fundamental challenges and flat financial performance in the latest quarter.

Read full news article

Brawn Biotech Ltd Downgraded to Strong Sell Amid Weak Financials and Technical Setbacks

2026-07-02 08:05:28

Brawn Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 1 July 2026. This decisive change reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid flat quarterly results and ongoing operating losses.

Read full news article

Brawn Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-06-23 08:04:46

Brawn Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 June 2026, driven primarily by a marked improvement in technical indicators. However, the company’s fundamental and valuation metrics remain weak, reflecting ongoing operational challenges and a precarious financial position. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.

Read full news article

View All News